R3i Ventures

What is R3i Ventures?

R3i Ventures is a venture capital firm based in Mapletee Business City, Singapore, with a focus on early-stage investments in DeepTech and MedTech sectors. They aim to identify companies that have growth potential on a global scale and can be built for scalability.

Their investment framework is designed to support companies through venture building, co-venturing, or spinning off ventures. R3i Ventures specializes in six pillars of early-stage DeepTech including Sustainable access to Healthcare (including MedTech), Renewable Energy, Food & Water; Connectivity & Computation; Space & Environment; Public Safety & Cybersecurity; Industrial Automation.

They seek disruptive scientific and technological advances that address critical global issues. R3i Ventures operates with an evergreen venture capital fund approach and provides advisory services, aligning with Smart City initiatives and future-forward sectors. With a strong focus on impact, they have curated a strategy that embeds environmental, social, and governance (ESG) principles into their investment decisions.

Their fund specializes in various stages including Early, Seed, Series A, and Series B rounds. Their financial engagements range from a minimum investment of $1,000,000 to a maximum of $5,000,000, with a sweet spot of around $2,000,000 per investment.

R3i Ventures does not engage with general technology companies or deals that are not cut out of Singapore, Delaware, or Luxembourg. Alongside investing, R3i Ventures operates an accelerator program that aims to tackle humanity's greatest challenges, creating industry leaders in climate, healthcare, and applied AI, and fostering technological and societal progress. With offices in Singapore and Delaware, United States, they facilitate cross-border operations and support.

What they say:

R3i Ventures takes advantage of the unique Smart City strategies of Singapore and Luxembourg, and the European Union’s deep tech funding initiatives. We then leverage the accelerated exit pathways available on Silicon Valley’s B+, and the Secondary markets.

What we look for: We invest in early-stage DeepTech and MedTech companies that have the potential to go global and can be venture built for scale, co-ventured, or spun off.

How we help: We take an active, hands-on approach that exploits our commercialization and domain expertise to curate, design, and nurture in Asia, scale into Europe, and exit cross border via Silicon Valley.